Navigation Links
Campbell Alliance to Moderate Senior-Level Panel Discussion at Windhover Pharmaceutical Strategic Alliances Conference
Date:9/21/2007

RALEIGH, N.C., Sept. 21 /PRNewswire/ -- Campbell Alliance, the leading management consulting firm specializing in the pharmaceutical and biotech industries, today announced that Ben Bonifant, Vice President and head of Campbell's Business Development practice, will moderate a panel discussion at the Pharmaceutical Strategic Alliances (PSA) conference hosted by Windhover Information. The conference will be held September 25-27, 2007 at The Marriott Financial Center in New York City.

The panel discussion, titled "Comparing the Long-Term Optimism of Platform Technologies to the Immediate Market Opportunities of Late-Stage Products," will explore whether a new technology needs to be demonstrated through the advancement of a late-stage product before a potential suitor is willing to discuss a deal. Scheduled for September 25 at 4:30 p.m., the panel will include participation from four senior-level industry executives with experience negotiating both platform technology and late-stage product deals. Mr. Bonifant will open the panel with a brief analysis of deal trends over the past 10 years involving platform technologies and late-stage products, as well as those deals that eventually advanced to an outright acquisition of the out- licensing company. The panel will then move into an interactive question and answer session.

"Over the past 10 years it has been interesting to watch the licensing environment for pharma and biotech products move from one that was very much in favor of licensing early-stage platform technologies to one that found the need wait until a technology was proven through the advancement of a derived compound to phase 2 or phase 3 of development," stated Bonifant. "In the past 18 months we've seen a resurgence of interest in platforms, with several development deals coming to fruition. Some notable deals even started as previous single-product relationships surrounding an innovative technology and resulted in outright acquisitions ju
'/>"/>

SOURCE Campbell Alliance
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Biomedical Alliance about more than stem cells
2. Doyle seeks $2.5M for biomedical alliance
3. Alliance looks to create the right chemistry in SE Wisconsin
4. Biomedical alliance marks first full year
5. New alliance to provide Wi-Fi network for City of Madison
6. Budget axe could cut SE Wisconsin tech alliance funding
7. Biotech Alliance pushes ahead in SE Wisconsin with likely state funding
8. Milwaukee research alliance sees need for incubator
9. University alliance gets $2.5 million to encourage minorities in science and technology
10. Suite Scheduler Announces Alliance with Ice Technologies
11. Alliance Brings E-Business Technologies to Wisconsin Manufacturers
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/30/2015)... June 30, 2015 /PRNewswire/ - RepliCel Life Sciences ... regenerative medicine company focused on the development of ... in its Phase 1/2 clinical trial of RCT-01, ... Achilles tendinosis, has been enrolled and their tissue ... injections. RCT-01 is comprised of non-bulbar dermal sheath ...
(Date:6/30/2015)... Tampa, Florida (PRWEB) , ... June 30, 2015 ... ... medical cannabis digital media company, launched “Cannavoices,” an unprecedented digital video and ... the largest but also the most dynamic collection of legal medical cannabis stories ...
(Date:6/29/2015)... ... June 29, 2015 , ... The global ... during the forecast period (2015 to 2020). The market is mainly driven by ... corporate funding for R&D. However, lack of adequate healthcare and research infrastructure in ...
(Date:6/29/2015)... , June 29, 2015  Neuralstem, Inc. (NYSE ... technology to develop small molecule and cell therapy treatments ... has been approved for listing on the NASDAQ Capital ... will continue to trade on the NYSE MKT until ... the NASDAQ Capital Market is expected to commence on ...
Breaking Biology Technology:RepliCel Life Sciences Enrolls First Participant in Phase 1/2 Clinical Trial of RCT-01 for Chronic Achilles Tendinosis 2RepliCel Life Sciences Enrolls First Participant in Phase 1/2 Clinical Trial of RCT-01 for Chronic Achilles Tendinosis 3RepliCel Life Sciences Enrolls First Participant in Phase 1/2 Clinical Trial of RCT-01 for Chronic Achilles Tendinosis 4Cannavoices Launches a Legal Medical Cannabis Documentary Initiative 2Cannavoices Launches a Legal Medical Cannabis Documentary Initiative 3Microfluidics Market Growing at 19.3% CAGR To 2020 – New research available at ReportsnReports.com 2Microfluidics Market Growing at 19.3% CAGR To 2020 – New research available at ReportsnReports.com 3Microfluidics Market Growing at 19.3% CAGR To 2020 – New research available at ReportsnReports.com 4Microfluidics Market Growing at 19.3% CAGR To 2020 – New research available at ReportsnReports.com 5Neuralstem, Inc. Announces Approval for Listing on the NASDAQ Capital Market 2Neuralstem, Inc. Announces Approval for Listing on the NASDAQ Capital Market 3
... tracking the number and dimension of particles or droplets as they ... are specific and possibly unique, changes that are of critical importance ... provide you with the knowledge, information and best practices you need ... ...
... of a new system to study crystallization processes for ... name,Crystalline. , The Crystalline has ... to learn as much as possible about a drug ... "Avantium is proud to launch its next system ...
... Institute have discovered a new method for controlling ... potentially one step closer to realizing the mass ... sheet of carbon, was discovered in 2004 and ... silicon as the fundamental building blocks of nanoelectronics. ...
Cached Biology Technology:Maximize Data Analysis with METTLER TOLEDO FBRM 2Avantium Launches the Crystalline, a New Parallel System for Crystallization Research 2Light-speed nanotech: Controlling the nature of graphene 2
(Date:6/24/2015)... , June 22, 2015 ... the addition of the "Huawei Ascend Mate ... report to their offering. Huawei,s technological ... the opposite direction than Apple,s and Samsung,s one. ... sensor developed by Fingerprint Cards, a main actor ...
(Date:6/23/2015)... 23, 2015   MedNet Solutions , an ... entire spectrum of clinical research, is pleased to ... , the company,s intuitive, flexible and affordable cloud-based ... 2015 Stevie® Award by the American Business ... Website category.  The American Business Awards are considered ...
(Date:6/23/2015)... , June 23, 2015   Valencell, ... announced the results of a recent study that ... on the wrist during activity. In a study ... was compared along with the Apple Watch against ... measuring heart rate during activity. The study demonstrated ...
Breaking Biology News(10 mins):Huawei Ascend Mate 7 Fingerprint Sensor - Reverse Costing Analysis 2MedNet Solutions' iMedNet eClinical Wins Silver Stevie Award 2Valencell Delivers Breakthrough Heart Rate Accuracy on the Wrist 2Valencell Delivers Breakthrough Heart Rate Accuracy on the Wrist 3
... vast majority of patients who had a successful ... need mitral valve surgery three years after their ... of the left ventricle (commonly known as reverse ... the Cardiovascular Research Foundations (CRF) nineteenth annual Transcatheter ...
... D.C. October 24, 2007 - The U.S. Senate ... Appropriations Bill (S.1710), including a provision that directs the ... Access Policy by requiring rather than requesting participation by ... House Appropriations Bill, which contains a similar provision, in ...
... Germany-October 24, 2007-Harvard University,s Office of Technology Development ... jointly establish the BASF Advanced Research Initiative. ... and Applied Sciences (SEAS) the initiative will benefit ... throughout the University. Set up as a ...
Cached Biology News:New data shows benefits of MitraClip for patients with mitral regurgitation 2New data shows benefits of MitraClip for patients with mitral regurgitation 3Mandate for public access to NIH-funded research poised to become law 2BASF and Harvard University announce extensive research collaboration 2
Synaptic Vesicle I Sampler Kit 10g each...
Mouse monoclonal [3A7.A11] to Thymidylate Synthase ( Abpromise for all tested applications). entrezGeneID: 7298 SwissProtID: P04818...
Mouse monoclonal [N7519] to NR0B2 ( Abpromise for all tested applications). Antigen: E.coli expressed recombinant full length protein (Human) NR0B2 Entrez Gene ID: 8431 Swiss Protein ID: ...
Integrins Sampler Kit 10g each...
Biology Products: